IceCure Expands ProSense® ChoICE Study for Low-Risk Breast Cancer adding Legacy Health in Portland, OR as U.S. Clinical Site

Go back to IceCure Expands ProSense® ChoICE Study for Low-Risk Breast Cancer adding Legacy Health in Portland, OR as U.S. Clinical Site
(NASDAQ: ICCM) Delayed: 1.08 --0 (-0%)
Previous Close $1.08    52 Week High $ 
Open $1.08    52 Week Low $ 
Day High $1.08    P/E N/A 
Day Low $1.08    EPS $ 
Volume 445